Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises KKR in the acquisition of Hyperion from Sandvik
Mandate

Vinge advises KKR in the acquisition of Hyperion from Sandvik

December 12, 2017 M&A Carve-Outs

Vinge is advising the listed US investment fund KKR on its acquisition of Hyperion, a manufacturer of industrial tool components, from Sandvik.

Hyperion has 1400 employees in a number of jurisdictions and about SEK 3.2 billion in turnover. The transaction is expected to close during the first half of 2018 and is subject to customary completion conditions such as merger filing approvals.

Vinge’s team has consisted of Christina Kokko, Kristina Ekberg, Alex Miler, Marith Welin-Berger and Matthias Pannier (M&A/Corporate), Eva Fredriksson, Mathilda Persson (TSA/IT), Tobias Kempas, Ilze Lukins, Sophia Holm (IP), Kristoffer Larson (real estate), Sara Strandberg (employment law) and Johan Cederlund and Hedvig Ekdahl (environmental).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026